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Abstract
Purpose The main research question is: BDo CFS patients
differ from fatigued non-CFS patients with respect to physical,
cognitive, behavioral, social, and emotional determinants?^ In
addition, group differences in relevant outcomes were
explored.
Method Patients who met the Centers for Disease Control
(CDC) criteria for CFS were categorized as CFS; these pa-
tients were mainly recruited via a large Dutch patient organi-
zation. Primary care patients who were fatigued for at least
1 month and up to 2 years but did not meet the CDC criteria
were classified as fatigued non-CFS patients. Both groups
were matched by age and gender (N=192 for each group).
Results CFS patients attributed their fatigue more frequently
to external causes, reported a worse physical functioning,
more medical visits, and a lower employment rate. The results
of a multiple logistic regression analysis showed that patients
who believe that their fatigue is associated with more severe
consequences, that their fatigue will last longer and is respon-
sible for more additional symptoms are more likely to be
classified as CFS, while patients who are more physically
active and have higher levels of Ball or nothing behavior^
are less likely to be classified as having CFS.
Conclusion A longitudinal study should explore the predic-
tive value of the above factors for the transition frommedical-
ly unexplained fatigue to CFS in order to develop targeted
interventions for primary care patients with short-term fatigue
complaints.
Keywords Chronic fatigue syndrome . Fatigue .Matched
case-control . Illness representations . Behavioral regulation
pattern . Psychosocial characteristics
Introduction
Fatigue can be defined as Ba sense of physical tiredness and
lack of energy, different from sadness and weakness^ [1].
About 18 to 39 % of the general adult population experiences
fatigue [2–5]. Fatigue can be seen as a continuum, ranging
from mild complaints to severe disabling and persisting fa-
tigue, like chronic fatigue syndrome (CFS) [6].
CFS is a chronic condition that is, according to the Centers
for Disease Control (CDC) criteria, characterized by unex-
plained, severe, and persistent fatigue lasting for at least
6 months; the fatigue is not due to ongoing exertion or to a
medical condition, is not improved by rest and may be wors-
ened by physical or mental exertion, significantly interferes
with daily activities and work, and is accompanied by four or
more out of eight other somatic symptoms [7]. The prog-
nosis of CFS is often poor with less than 10 % returning
to premorbid levels of functioning if the condition is left
untreated [8].
Several studies have shown that CFS patients differ from
fatigued non-CFS patients [9–11]. Fatigue in CFS patients is
often more severe than in fatigued non-CFS patients, and CFS
patients report more somatic symptoms. CFS patients more
frequently believe that their fatigue will last for a very long
time and will be associated with more adverse consequences,
but CFS patients and fatigued non-CFS patients do not seem
to differ in perceptions of control over their fatigue [9].
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Furthermore, studies have shown that CFS patients attribute
their illness rather to external physical causes than to internal
or psychological causes [12, 13], and their levels of psycho-
logical distress are higher [9–11]. In terms of outcomes, CFS
patients are found to be less able to conduct everyday activi-
ties, their level of physical functioning is lower, they visit
more frequently their general practitioner (GP), have a higher
absenteeism from work, and a lower employment rate [9–11].
Each of the above studies has, however, included only a lim-
ited set of determinants and varied importantly in terms of the
comparison group that was used, depending upon the research
question.
As it proves to be very difficult to influence CFS once it is
firmly established, efforts should be directed at interventions
at an earlier stage, targeting determinants that discriminate
significantly between a non-CFS group and a CFS group, as
these factors could also be responsible for a transition from
short-term fatigue to CFS. The present study aims at identify-
ing such determinants. The broad range of physical, cognitive,
behavioral, social, and emotional determinants included in the
present study was selected based on reviews of factors that
may play a role in the development and maintenance of CFS
[14–17] and the comparative studies cited above [9–13].
The present study is a matched case-control study includ-
ing a broad set of modifiable determinants and some relevant
outcomes. The central research question is: Do CFS patients,
who meet the CDC criteria, differ from fatigued non-CFS
patients, reporting fatigue for at least 1 month up to 2 years,
with respect to physical (sleep, physical activity), cognitive
(illness representations), behavioral (all or nothing and limit-
ing behavior), social (social support), and emotional determi-
nants (anxiety, depression)? In addition, group differences in a
number of relevant outcomes (physical functioning, work sta-
tus, and medical visits) were explored.
Methods
Participants and Procedure
CFS patients were recruited from a large Dutch patient orga-
nization and filled in an online questionnaire. Patients
reporting fatigue of at least 1-month (but less than 2 years)
duration were recruited via primary health care centers and
completed the same online questionnaire. All participants
signed an informed consent before taking part in the study.
Participants who had a concurrent somatic condition that
could explain the fatigue symptoms or those who had a severe
psychiatric disorder were excluded from the study. The inclu-
sion or exclusion was done on the basis of self-report.
A total of 723 patients completed the questionnaire. One-
hundred and twenty-one participants were excluded due to
missing data and 39 due to the presence of a somatic condition
and/or psychiatric disorder. The final sample consisted of 563
participants. Participants were then categorized as CFS cases
if they met the CDC criteria for CFS. Participants who report-
ed fatigue for at least 1 month but did not meet the CDC
criteria for CFS were categorized as fatigued non-CFS cases.
The CDC criteria were assessed on the basis of a self-report
questionnaire [18]. A total of 267 were categorized as CFS
cases (202 of the patient organization and 65 of the primary
care group) and 296 as fatigued non-CFS cases (all from the
primary care group). Both groups were subsequently matched
by age and gender using the SPSS plugin FUZZY. The final
matched sample consisted of 192 CFS and 192 fatigued non-
CFS cases. The mean age of the CFS group was 40.50
(SD=12.20), and themean age of the fatigued non-CFS group
was 40.22 (SD=12.20). Both groups consisted of 22 males
(11.5 %) and 170 females (88.5 %).
Measures
Patient Characteristics Include Age, Gender, and
Educational Level
Fatigue and Somatic Complaints
Fatigue severity was assessed using the subjective experience
of fatigue subscale of the Checklist Individual Strength (CIS-
20R) [19] with higher scores indicating more fatigue.
Fatigue duration was assessed by means of self-report
(number of weeks/months fatigued).
Somatic complaints were assessed with the Patient Health
Questionnaire-15 [20]. Higher scores indicate more somatic
complaints.
Determinants
Sleep was measured by asking participants to indicate the
average amount of hours they sleep per night.
Physical activity levels were measured using the Short
Questionnaire to Asses Health Enhancing Physical Activity
[21]. Higher scores indicate more physical activity.
Patients’ illness representations were assessed using the
Brief Illness Perception Questionnaire (Brief IPQ) [22].
Higher scores on the dimensions consequences, timeline,
identity, and emotional representation indicate more severe
consequences, a longer expected fatigue duration, more addi-
tional symptoms, and more emotional consequences. Higher
scores on personal control, treatment control, and understand-
ing indicate higher beliefs in personal or treatment control and
more understanding of one’s fatigue. For the cause dimension,
patients were given a list of nine potential causes and had to
indicate for each of these causes if they considered it to be a
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potential cause of their fatigue/CFS or not (making use of a
yes/no scale).
Behavioral regulation patterns were measured using the
Ball or nothing^ (a pattern of over-activity followed by rest)
and Blimiting behavior^ (reducing daily activities and exces-
sive resting) scales of the Behavioral Reponses to Illness
Questionnaire (BRIQ) [23]. Higher scores indicate more Ball
or nothing^ or Blimiting behavior.^
Social support was measured with two questions: BHow
much social support do you receive from your partner (best
friend or family member) for your fatigue?^ and BHow much
social support do you receive from others who are not your
partner (best friend or family member)?,^ rated on a 5-point
Likert scale ranging from ‘no support’ to Ba lot of support.^
Psychological distress was assessed with the anxiety and
depression subscales of the Brief Symptom Inventory
(BSI) [24].
Outcome Variables
Physical functioning was assessed using the Short Form
Health Survey (SF-12 v2) [25]. Lower scores indicate worse
physical functioning.
Employment status and medical visits during the past
6 months were assessed by self-report.
Statistical Analysis
First, comparisons between the CFS and the fatigued non-CFS
group were made using independent t tests for normally dis-
tributed continuous variables, Mann–Whitney U tests for non-
normally distributed continuous variables, and χ2 for categor-
ical variables. To reduce the chances of obtaining false-
positive results, due to multiple comparisons, a Bonferroni
correction was used. The Bonferroni-corrected alpha level that
corresponds with an alpha level of 0.05 was 0.002 (0.05/30).
All p values lower or equal to 0.002 were considered to be
significant. All tests performed were two-tailed tests.
Next, a multivariate logistic regression analysis was con-
ducted to identify which determinants contributed most to the
likelihood of being diagnosed with CFS. The analyses were
conducted using SPSS v21 for windows.
Results
Table 1 shows the results of the comparative tests.With regard
to patient characteristics, no significant differenceswere found
for age or gender, as subjects were matched for both age and
gender. No significant difference was found for educational
level. CFS patients reported a significantly longer duration of
fatigue, a higher fatigue severity, and more somatic com-
plaints than fatigued non-CFS patients.
In terms of physical, cognitive, behavioral, social, and
emotional determinants, univariate differences were found
for average hours of sleep per night, minutes of physical ac-
tivity per week, perceived consequences, timeline, treatment
control and identity (illness beliefs), Blimiting^ and Ball or
nothing behavior.^. Non-CFS patients more frequently attrib-
uted their fatigue to Bstress^ or Btheir own behavior^ (internal
causes) than CFS patients, while CFS patientsmore frequently
attributed their fatigue to Ba germ or virus,^ Bchance,^ and
Bpoor medical care in the past^ (external and physical causes).
No significant differences were found for social support, anx-
iety, and depression.
With respect to relevant outcomes, the fatigued non-CFS
group reported a significantly better physical functioning, a
higher employment rate, and less medical visits.
Next, a multivariate logistic regression analysis was con-
ducted to identify which determinants contribute most to the
likelihood of being diagnosed with CFS. Only determinants
that were significant at a univariate level (see Table 1) were
entered as independent variables into the equation. Fatigue
duration, fatigue severity, and somatic complaints were not
entered as control or independent variables in the equation
because they were part of the inclusion criteria used to con-
struct the dependent variable. The Bcause^ variable of the
Brief IPQ was not entered into the regression analysis as pa-
tients could indicate multiple causes for their fatigue/CFS.
Multicollinearity did not prove to be an issue. The linearity
of the logit assumption was tested using the Box-Tidwell test.
As physical activity (min/day) (PA) violated the linearity of
the logit assumption, a categorical variable for PA was used
based on the median. All other variables entered into the mod-
el were continuous. Table 2 shows the results of the logistic
regression analysis.
The regression model was statistically signficant, χ2(8,
N=384) = 165.98, p< .001), indicating that the model was
able to distinguish between the two patient groups. The model
explained between 35.1 % (Cox & Snell R2) and 46.8 %
(Nagelkerke R2) of the variance in the dependent variable
and correctly classified 76.6 % of the cases. Patients with
higher consequences, timeline, and identity beliefs were more
likely to be classified as having CFS. In contrast, persons with
higher levels of PA and higher levels of BAll or Nothing^
behavior were less likely to be classified as having CFS.
Discussion
Main Findings
As expected, CFS patients reported higher levels of fa-
tigue severity, a longer duration of fatigue, and more
somatic complaints.
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Table 1 Descriptives of and differences between the CFS and fatigued non-CFS patients
Variable Non-CFS N= 192 CFS N= 192 Test for differences 95 % CIa p Effect size r
Patient characteristics
Age, years 40.22 ± 12.08 40.50 ± 12.20 t = −.227 −2.72, 2.16 .821 –
Gender (female) 170 (88.5) 170 (88.5) – –
Educational level (N, %) χ 2 = 4.63 – .111 –
Primary educationb 1 (0.5) 7 (3.6)
Secondary education 53 (27.6) 53 (27.6)
Higher education 138 (71.9) 132 (68.8)
Fatigue and somatic complaints
Fatigue severity 43.97 ± 6.81 47.83 ± 7.31 U = 12176.5 – .000 −.29
Fatigue duration, weeks 40.30 ± 30.93 454.85 ± 459.52 U = 4393 – .000 −.66
Somatic complaints 11.07 ± 4.50 14.23 ± 4.54 t = −6.86 −4.07, 2.26 .000 −.33
Determinants
Average hours of sleep per night c 7.01 ± 1.43 7.55 ± 1.81 t = −3.25 −0.87, −0.21 .001 −.16
Minutes of PA per week 221.68 ± 304.67 154.98 ± 541.20 U = 12064.5 – .000 .30
Illness representations
Consequence 6.93 ± 1.73 8.50 ± 1.57 U = 8981.5 – .000 −.41
Timeline 5.39 ± 1.99 7.57 ± 1.95 t = −10.86 −2.58, −1.79 .000 −.48
Personal control 4.48 ± 2.00 4.13 ± 2.13 t = 1.68 −0.06, 0.77 .094 –
Treatment control 3.44 ± 2.56 4.47 ± 2.58 t = −3.95 −1.55, −0.52 .000 −.20
Identity 5.33 ± 2.24 7.41 ± 2.08 U = 8510 – .000 −.05
Understanding 6.23 ± 2.43 5.71 ± 2.65 t = 1.99 0.01, 1.03 .048 –
Emotional representationc 6.01 ± 1.65 6.34 ± 2.02 t = −1.74 −1.40, −0.08 .083 –
Attributions of fatigue (N, %)
A germ or virus 35 (18.2) 120 (62.5) χ 2 = 78.16 – .000 −.45
Diet or eating habits 75 (39.1) 63 (32.8) χ 2 = 1.63 – .202 –
Pollution 31 (16.1) 31 (16.1) χ 2 = 0.00 – 1.00 –
Hereditary 19 (9.9) 30 (15.6) χ 2 = 2.83 – .092 –
Chance 41 (21.4) 69 (35.9) χ 2 = 9.99 – .002 −.16
Stress 160 (83.3) 128 (66.7) χ 2 = 14.22 – .000 .19
My own behavior 105 (54.7) 65 (33.9) χ 2 = 16.89 – .000 .21
Others behavior 85 (44.3) 58 (30.2) χ 2 = 8.12 – .004 –
Poor medical care 8 (4.2) 38 (19.8) χ 2 = 22.23 – .000 −.24
Limiting behaviorc 18.88 ± 4.58 22.43 ± 5.07 t = −7.19 −4.52, −2.58 .000 −.34
All or nothing behavior 16.59 ± 5.61 14.89 ± 4.68 t = 3.17 0.65, 2.76 .002 .16
Social support 6.68 ± 1.65 6.60 ± 1.83 U = 18388.5 – .968 –
Depression 6.83 ± 5.29 6.88 ± 5.61 U = 18185.5 – .820 –
Anxiety 6.00 ± 5.22 6.09 ± 5.26 U = 18241 – .860 –
Outcome variables
Physical functioning 58.09 ± 19.00 35.75 ± 20.26 t = 11.15 18.40, 26.28 .000 .49
Employment status (N, %) χ 2 = 72.12 – .000 .27
Working, fulltime 63 (32.8) 16 (8.3)
Working, part-time 81 (42.2) 71 (37.0)
Not working 27 (14.1) 96 (50.0)
Studying 21 (10.9) 9 (4.7)
Medical visits, no. 3.45 ± 3.84 4.49 ± 4.60 U = 15145.5 - .002 −.16
Values are the mean ± SD unless otherwise indicated. Bonferroni corrected 0.05 alpha level 0.002
PA physical activity
aConfidence interval of the difference
bMore than 20 % of cells had expected count less than 5, an exact significance test was selected for Pearson’s χ2
cLevene’s test of equal variance not assumed
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CFS and fatigued non-CFS patients also differed in their
causal attribution of fatigue. CFS patients more frequently
attributed their fatigue to external and physical causes and
non-CFS patients to internal causes. This is in line with the
results of other studies [12, 13]. Attribution of symptoms to
physical causes has been previously associated with decreased
physical activity and higher fatigue in CFS patients, suggest-
ing that this attribution tendency is a maintaining factor [13].
In contrast with the study by Darbishire et al. [9] and
Evengård et al. [11], we did not find differences in anxiety
and depression between both groups. Differences in measure-
ment instruments and study setting could partly explain this
finding. The results of both previous studies could also be
subject to a type 1 error, as no statistical correction for multiple
comparisons was made.
As expected, CFS patients reported worse physical func-
tioning and a lower employment rate than the fatigued non-
CFS group. This is in line with other studies [9, 10]. As in the
study by Darbishire et al. [9], CFS patients also paid signifi-
cantly more visits to their GP and medical specialists.
The results of the multiple logistic regression analysis
showed that patients who are more physically active are less
likely to be classified as CFS. The amount of sleep per night
was not a significant determinant. With regard to illness rep-
resentations, the results showed that patients who believed
that their fatigue was associated with more severe conse-
quences, that it would last for a longer period of time, and
patients who attributed more additional symptoms to their
condition were more likely to be classified as CFS, a finding
that is similar to other studies [9, 16]. Finally, patients who
reported lower levels of Ball or nothing behavior^ were more
likely to have a CFS diagnosis. This finding may suggest that
Ball-or-nothing^ behavior is more characteristic of the earlier
stages of fatigue, which is in line with a prospective cohort
study [16], demonstrating that, within a patient cohort suffer-
ing from an acute viral infection, Ball-or-nothing^ behavior
was a strong predictor of the development of CFS over time.
Limitations and Strengths
A limitation of this study is that the diagnosis of CFS
was based on a self-report measure, which could have
led to misclassification of some patients. Likewise, the
presence of other somatic diseases and/or psychiatric dis-
orders was not ruled out by means of clinical evalua-
tions. The fact that both groups were for the most part
recruited in a different way (patient organization for CFS
versus primary health care centers for the non-CFS pa-
tients) may also have influenced the results. The present
study included only quantity of sleep at night. Future
studies should also take into account the amount of time
spent sleeping during the day, as well as sleep quality,
thus allowing for a more complete measurement of the
sleep variable. In addition, other potentially important
physical determinants such as BMI should also be taken
into account in future studies.
Another limitation is the cross-sectional design of the
study which does not allow for conclusions about the di-
rection of significant associations. In the present study,
there is, e.g., a significant difference in fatigue duration
and severity between both study groups, which is, howev-
er, most likely due to the inclusion criteria used to distin-
guish between the CFS and the non-CFS group. In addi-
tion, other significant differences that were found (e.g., in
physical activity and all-or-nothing behavior) are not nec-
essarily precursors, but could also be consequences of be-
ing faced with chronic fatigue. For this reason, future pro-
spective studies are needed to examine whether these fac-
tors are indeed risk factors for developing CFS.
An important strength of the present study, compared
to other case control studies, is its sample size as well as
the fact that the CFS and the fatigued non-CFS patients
were matched by age and gender. In addition, this is the
first study to include so many potential determinants of a
distinction between both groups.
Table 2 Predictors of chronic
fatigue syndrome (N= 384) Predictors β SE Wald OR 95 % CI
b p
Constant −5.59 1.04 28.99 .00 .000
Sleep .043 .084 .268 1.044 0.89-1.23 .605
Min of PA per week (high)a b −.744 .270 7.610 .475 0.28-0.81 .006
Consequence .302 .097 9.682 1.353 1.12-1.64 .002
Timeline .428 .071 36.426 1.530 1.34-1.76 .000
Treatment Control .009 .054 .028 1.009 0.91-1.12 .868
Identity .170 .073 5.337 1.185 1.03-1.37 .021
All or nothing behavior −.062 .025 5.954 .940 0.90-0.99 .015
Limiting behavior .020 .033 .376 1.020 0.96-1.09 .540
aMinutes of physical activity per week
bMedian minutes of PA per week = 100
b Confidence interval of the difference
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Conclusion
CFS patients and fatigued non-CFS patients appear to differ in
many respects. The differences found in this study with re-
spect to physical, cognitive, and behavioral factors may point
at potential risk factors for the transition from medically un-
explained fatigue to CFS. A prospective study should explore
the predictive value of these risk factors in order to develop a
screening instrument that would allow for identifying primary
care patients at risk at an early stage in view of the develop-
ment of interventions.
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